Putnam Capital Spectrum Y a Zacks Rank #3 (Hold) seeks total return. PVSYX invests in equity and fixed-income securities, including floating and fixed rate bank loans and both growth and value stocks, of companies of any size that the adviser believes have favorable investment potential.
This Allocation Balanced fund, as of the last filing, allocates their fund in three major groups; Small Growth and Foreign Stock. Further, as of the last filing, JAZZ PHARMACEUTICALS PLC, DISH NETWORK CORP A and ECHOSTAR CORP were the top holdings for PVSYX.
The Putnam Capital Spectrum Y fund, managed by Putnam Funds, carries an expense ratio of 0.71%.
PVSYXhas a history of positive total returns for over 10 years. Specifically, the fund’s returns over the 1, 3, 5 year benchmarks; 1 year 17.19%, 3 year 5.01% and 5 year 12.27%. To see how this fund performed compared in its category and other #1 and #2 Ranked Mutual Funds, please click here.
PVSYX’s performance, as of the last filing, when compared to funds in its category was in the top 2% in 1 year, top 43% over the past 3 years, and in the 1% over the past 5 years.
Want key mutual fund info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing mutual funds, each week. Get it free >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Putnam Capital Spectrum Y a Zacks Rank #3 (Hold) seeks total return. PVSYX invests in equity and fixed-income securities, including floating and fixed rate bank loans and both growth and value stocks, of companies of any size that the adviser believes have favorable investment potential.
This Allocation Balanced fund, as of the last filing, allocates their fund in three major groups; Small Growth and Foreign Stock. Further, as of the last filing, JAZZ PHARMACEUTICALS PLC, DISH NETWORK CORP A and ECHOSTAR CORP were the top holdings for PVSYX.
The Putnam Capital Spectrum Y fund, managed by Putnam Funds, carries an expense ratio of 0.71%.
PVSYXhas a history of positive total returns for over 10 years. Specifically, the fund’s returns over the 1, 3, 5 year benchmarks; 1 year 17.19%, 3 year 5.01% and 5 year 12.27%. To see how this fund performed compared in its category and other #1 and #2 Ranked Mutual Funds, please click here.
PVSYX’s performance, as of the last filing, when compared to funds in its category was in the top 2% in 1 year, top 43% over the past 3 years, and in the 1% over the past 5 years.
Want key mutual fund info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing mutual funds, each week. Get it free >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>